Literature DB >> 2469045

Galanin-like immunoreactivity is present in human substantia innominata and in senile plaques in Alzheimer's disease.

N W Kowall1, M F Beal.   

Abstract

Galanin immunoreactivity has been shown to be present in cholinergic magnocellular basal forebrain neurons in both rat and monkey brain. In the present study galanin immunoreactivity in human substantia innominata was found in both the magnocellular neurons of the nucleus basalis of Meynert and in a dorsomedial group of intensely immunoreactive parvocellular neurons. Scattered galanin-immunoreactive fibers, but no immunoreactive neurons, were found in normal human cerebral cortex. Galanin-immunoreactive neurites were found in a small number of senile plaques in the hippocampus and temporal isocortex of Alzheimer's disease patients. The existence of galanin immunoreactivity in human magnocellular basal forebrain neurons which are depleted in Alzheimer's disease suggests that galanin may be similarly affected.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2469045     DOI: 10.1016/0304-3940(89)90384-4

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

Review 1.  Galanin-acetylcholine interactions in rodent memory tasks and Alzheimer's disease.

Authors:  M P McDonald; J N Crawley
Journal:  J Psychiatry Neurosci       Date:  1997-11       Impact factor: 6.186

Review 2.  Galanin and its receptors in neurological disorders.

Authors:  Linda Lundström; Anna Elmquist; Tamas Bartfai; Ulo Langel
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 3.  Neuroprotective role for galanin in Alzheimer's disease.

Authors:  Scott E Counts; Sylvia E Perez; Stephen D Ginsberg; Elliott J Mufson
Journal:  Exp Suppl       Date:  2010

4.  Coexpression of galanin and adrenocorticotropic hormone in human pituitary and pituitary adenomas.

Authors:  D W Hsu; S C Hooi; E T Hedley-Whyte; R M Strauss; L M Kaplan
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

Review 5.  Galanin in Alzheimer's disease: neuroinhibitory or neuroprotective?

Authors:  S E Counts; S E Perez; E J Mufson
Journal:  Cell Mol Life Sci       Date:  2008-06       Impact factor: 9.261

6.  Effect of neocortical and hippocampal amyloid deposition upon galaninergic and cholinergic neurites in AβPPswe/PS1ΔE9 mice.

Authors:  Christy M Kelley; Sylvia E Perez; Cassia R Overk; David Wynick; Elliott J Mufson
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

7.  Differential expression of galanin in the cholinergic basal forebrain of patients with Lewy body disorders.

Authors:  Athanasios Alexandris; Alan King Lun Liu; Raymond Chuen-Chung Chang; Ronald K B Pearce; Steve M Gentleman
Journal:  Acta Neuropathol Commun       Date:  2015-12-01       Impact factor: 7.801

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.